Phillip M. Pierorazio MD
Assistant Professor of Urology and Oncology, James Buchanan Brady Urological Institute, Department of Urology and Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
Dr. Phillip M. Pierorazio, joined the staff of the James Buchanan Brady Urological Institute, Department of Urology and Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as an Assistant Professor of Urology and Oncology. Prior to starting residency, he was accepted and spent a year as a Doris Duke Clinical Research Fellow in Urologic Oncology. Dr. Pierorazio has expertise in all malignancies of the urinary tract, performs both open and minimally-invasive surgeries including laparoscopic and robotic surgeries of the kidney, bladder and prostate, but has a special interest in kidney cancer, including partial nephrectomy for early stage disease and high-risk surgeries for patients with advanced urological cancers. Paralleling his clinical interests, runs the Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) Registry – one of the largest studies of its kind – following patients with small, localized kidney tumors (cT1a, ≤4cm) who choose active surveillance or immediate surgery. The National Comprehensive Cancer Network (NCCN) recently awarded Dr. Pierorazio a Young Investigator’s Award for his work with the DISSRM Registry. In addition, Dr. Pierorazio is the Director of Testicular Cancer and Director of Social Media at the Brady Urological Institute. Dr. Pierorazio is the recipient of a number of academic awards including the American Urologic Association Essay Contest and has presented his research at a number of national and international meetings. He has written and published numerous research articles, textbook chapters, and video presentations in the field Urologic Oncology.
Recent Contributions to PracticeUpdate:
- Laparoscopic Retroperitoneal Lymph Node Dissection in Patients With Metastatic Nonseminomatous Germ Cell Tumors
- Impact of VTE on Mortality and Morbidity During Nephrectomy for a Renal Mass
- Perspectives on the Role of Biopsy for Management of T1 Renal Masses
- Outcomes After Cytoreductive Surgery for Metastatic Upper Tract Urothelial Carcinoma
- Association of Surgical Delay and Overall Survival in Patients With T2 Renal Masses
- Burden of In-Person Kidney Cancer Surveillance in a Low-Resource Population
- Long-Term Oncologic Outcomes After Primary Retroperitoneal Lymph Node Dissection
- Urothelial Carcinoma of the Renal Pelvis vs Ureter
- Active Surveillance for Renal Masses: Where Are We in 2016